Clinical Trial Update: Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating haploidentical hematopoietic stem cell transplantation in patients with Wiskott-Aldrich syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wiskott-aldrich Syndrome

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Wiskott-Aldrich Syndrome | Phase 1 | Status: COMPLETED